- Home
- VIR vs IDT Comparison
VIR vs IDT Comparison
Compare VIR & IDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIR
- IDT
- Stock Information
- Founded
- VIR 2016
- IDT 1990
- Country
- VIR United States
- IDT United States
- Employees
- VIR N/A
- IDT N/A
- Industry
- VIR Biotechnology: Pharmaceutical Preparations
- IDT Telecommunications Equipment
- Sector
- VIR Health Care
- IDT Telecommunications
- Exchange
- VIR Nasdaq
- IDT Nasdaq
- Market Cap
- VIR 1.4B
- IDT 1.3B
- IPO Year
- VIR 2019
- IDT 1996
- Fundamental
- Price
- VIR $7.00
- IDT $47.28
- Analyst Decision
- VIR Buy
- IDT
- Analyst Count
- VIR 6
- IDT 0
- Target Price
- VIR $35.67
- IDT N/A
- AVG Volume (30 Days)
- VIR 1.1M
- IDT 98.6K
- Earning Date
- VIR 05-01-2025
- IDT 03-06-2025
- Dividend Yield
- VIR N/A
- IDT 0.50%
- EPS Growth
- VIR N/A
- IDT 117.27
- EPS
- VIR N/A
- IDT 3.15
- Revenue
- VIR $74,205,000.00
- IDT $1,221,391,000.00
- Revenue This Year
- VIR N/A
- IDT N/A
- Revenue Next Year
- VIR $17.69
- IDT N/A
- P/E Ratio
- VIR N/A
- IDT $15.11
- Revenue Growth
- VIR N/A
- IDT 1.75
- 52 Week Low
- VIR $6.56
- IDT $33.84
- 52 Week High
- VIR $14.45
- IDT $58.77
- Technical
- Relative Strength Index (RSI)
- VIR 28.28
- IDT 44.87
- Support Level
- VIR $6.96
- IDT $45.07
- Resistance Level
- VIR $7.46
- IDT $52.47
- Average True Range (ATR)
- VIR 0.57
- IDT 1.64
- MACD
- VIR -0.16
- IDT -0.02
- Stochastic Oscillator
- VIR 1.56
- IDT 29.86
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
About IDT IDT Corporation Class B
IDT Corp is a multinational holding company. It operates in the telecommunications and payment industries. It has four reportable business segments, Fintech, National Retail Solutions; net2phone and Traditional Communications, The Fintech segment is comprised of National Retail Solutions (NRS), an operator of a nationwide point of sale (POS) network providing payment processing, digital advertising, transaction data, and ancillary services, and BOSS Money, a provider of international money remittance and related value/payment transfer services. The net2phone segment provides unified cloud communications and telephony services to business customers.